Mario Alba is a partner in Robbins Geller Rudman & Dowd LLP’s Melville office. He is a member of the Firm’s Institutional Outreach Team, which provides advice to the Firm’s institutional clients, including numerous public pension systems and Taft-Hartley funds throughout the United States, and consults with them on issues relating to corporate fraud in the U.S. securities markets, as well as corporate governance issues and shareholder litigation. Some of Alba’s institutional clients are currently involved in securities cases involving Avalara, Inc., Clarivate plc, Dentsply Sirona Inc., Generac Holdings Inc., Globe Life Inc., Amgen, Inc., Virtu Financial, Inc., The Walt Disney Company, The Boeing Company, Merck & Co., Inc., Daimler, Novo Nordisk, and National Instruments Corporation.
Alba’s institutional clients are/were also involved in other types of class actions, namely, In re National Prescription Opiate Litigation (over $50 billion paid to communities across the country), In re Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation ($609 million total recovery), Forth v. Walgreen Co. ($100 million recovery), and In re Humira (Adalimumab) Antitrust Litigation.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers | 2026 | Complex Securities Litigation |
| The 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers | 2025 | Complex Securities Litigation |
| The 2024 Lawdragon 500 Leading Plaintiff Financial Lawyers | 2024 | Complex Securities Litigation |
Alba has served as lead counsel in numerous cases and is responsible for initiating, investigating, researching, and filing securities and consumer fraud class actions. He has recovered hundreds of millions of dollars in numerous actions, including cases against Acadia Healthcare Company, Inc. ($179 million recovery); BHP Billiton Limited ($50 million recovery), Equinix, Inc. ($41.5 million recovery), Green Dot Corporation ($40 million recovery), BRF S.A. ($40 million recovery), L3 Technologies, Inc. ($34.5 million recovery), Impax Laboratories Inc. ($33 million recovery), Waste Management, Inc. ($30 million recovery), Reckitt Benckiser Group plc ($19.6 million recovery), Super Micro Computer, Inc. ($18.25 million recovery), and NBTY, Inc. ($16 million recovery).
Alba has lectured at numerous institutional investor conferences throughout the United States on various shareholder issues, including at the National Labor & Management Conference (NLMC), National Conference on Public Employee Retirement Systems (NCPERS), Opal Public Funds Summit, Koried Plan Sponsor Educational Institute, Georgia Association of Public Pension Trustees (GAPPT) Annual Conference, Illinois Public Pension Fund Association, the New York State Teamsters Conference, the American Alliance Conference, and the TEXPERS/IPPFA Joint Conference at the New York Stock Exchange, among others.
Alba has been named a Leading Plaintiff Financial Lawyer by Lawdragon. The Union Labor Advisory (ULA) Network awarded him the Service to Community Award in November 2025. He graduated from St. John’s University with a Bachelor of Science degree in Finance, with distinction. He earned his Juris Doctor degree from Hofstra University School of Law. While in law school, he was selected to participate in the Hofstra Moot Court Seminar and was an active member of the Student Bar Association. During his summers between law school, Alba clerked at the Firm, investigating and researching potential securities class actions and antitrust lawsuits. Alba is fluent in Italian and holds dual citizenship.